Drug-induced AKI (acute kidney injury) is common and may include medications not previously known to exhibit this safety signal.

Detailed price information for Seastar Medical Hldg Corp (ICU-Q) from The Globe and Mail including charting and trades.

Background: Patients on anti-tuberculosis treatment may develop acute kidney injury (AKI), but little is known about the renal outcome and prognostic factors, especially in an aging population.

Acute kidney injury (AKI) often occurs as a result of ischemia, which is a condition in which blood flow to part of the body ...

Kidney disease results from kidney damage and subsequent decline in kidney function, says Dr. Pooja Budhiraja, a nephrologist ...

SeaStar Medical (ICU) announces the activation of Sentara Norfolk General Hospital in Norfolk, Virginia as its thirteenth active site in its ...

SeaStar Medical is progressing its pivotal trial evaluating the use of its Selective Cytopheretic Device (SCD) in patients with acute kidney injury (AKI), with the company announcing that 12 ...

“The pace of enrollment in our NEUTRALIZE-AKI trial has quickly accelerated, with 14 new subjects enrolled in slightly more than six weeks,” said Kevin Chung, MD, Chief Medical Officer of ...

SeaStar Medical (ICU) Holding reports setting a new monthly enrollment record with 10 critically ill acute kidney injury patients added to the NEUTRALIZE-AKI pivotal trial during the past month ...

SeaStar Medical also markets a pediatric version of the device, QUELIMMUNE™, for children with AKI and sepsis, which was approved by the FDA earlier this year under a Humanitarian Device Exemption.